Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1789 USD | +8.42% | +23.38% | -8.26% |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
Financials (USD)
Sales 2022 | 0.27 | Sales 2023 | - | Capitalization | 239M |
---|---|---|---|---|---|
Net income 2022 | -211M | Net income 2023 | -79M | EV / Sales 2022 | 989,524,989 x |
Net Debt 2022 | 32.57M | Net Debt 2023 | 33.01M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
1 day | +8.42% | ||
1 week | +23.38% | ||
Current month | +27.79% | ||
1 month | +20.88% | ||
3 months | +7.13% | ||
6 months | +3.41% | ||
Current year | -8.26% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | Nov. 16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | Jan. 31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 22-10-12 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 22-08-23 |
Karen Brunke
BRD | Director/Board Member | 72 | 22-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 0.1789 | +8.42% | 2,247,465 |
24-05-15 | 0.165 | -1.84% | 477,735 |
24-05-14 | 0.1681 | +14.33% | 869,691 |
24-05-13 | 0.147 | +0.99% | 338,112 |
24-05-10 | 0.1456 | +0.41% | 410,870 |
Delayed Quote OTC Markets, May 16, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-8.26% | 164M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- CYDY Stock